• Аnastasiia Aksonova National O.O. Bogomolets Medical UniversityPerinatal center
  • Iryna Ventskovskaya National O.O. Bogomolets Medical UniversityPerinatal center
  • Tatyana Yuzvenko Ukrainian Scientific-Practical Centre of Endocrine Surgery Transplantation of Endocrine Organs and Tissues Ministry of Health of Ukraine
Keywords: pre-eclampsia, atherogenic parameters, cardiac indices, LDH


Aim of the work. The study of interconnection between atherogenic parameters of the blood serum and cardiac indices during pregnancy with the risk of pre-eclampsia development and prognostication of remote cardio-vascular and/or metabolic pathology among pregnant.

Materials and methods. The indices of lipid metabolism in the blood serum of 267 pregnant women were studied using diagnostic sets of reagents. The blood sampling was carried out in II (16-24 gestational weeks) trimester. The general cholesterol (GC) and triglycerides (TG) were determined by colorimetric and enzymatic method; high-density lipoproteins – HDL – by homogenous method of direct determination of HDL-cholesterol concentration in the blood serum without preliminary processing and centrifugation, low-density lipoproteins – LDL – by the direct method. VLDL concentration was calculated by Friedewald formula: LDL = TG/2,2.  

For evaluation of GC-VLDL concentration TG/2,2 parameter is used, if TG concentration is expressed in mmol/l (or TG/5, if concentration is expressed in mg/100 ml).

Cardiac indices were calculated taking into account the lipid parameters according to the correspondent mathematical formulas. Lactate and LDH concentrations were determined by optimized method using diagnostic reagents.  Lactate concentration was determined at the use of diagnostic set for determination of lactate concentration, and DLH was also determined by diagnostic set for determination of LDH (DL) activity by optimized method, elaborated taking into account the recommendations of German Association of clinical chemistry (DGKC) after correspondent calibration of automatic analyzer ACCENT-200 II GEN. Depending on the development of clinical presentation of PE 43 women were divided in groups with light and middle severity of course of this pathology.

Results and discussionAmong the women with PE development was observed the essential changes in II trimester in the aspect of atherogenic parameters and cardiac indices mainly at the expense of progressing increase of TG in the blood serum (mmol/l: I group - 1,73 ± 0,14, II group - 1,86 ± 0,18 comparing with III control group - 1,51 ± 0,06. The gradual growth of cardiac (atherogenic) indices - AIP, CR and CА and connection between AIP and the levels of maternal serumal TG and arterial pressure were observed in women with PE development at the absence of such connection among the women of control group (p <0,05) . LDH level grew with the progressing of PE severity: for the women of I group LDH level was - 389 ± 1,6 U/l at 778 ± 0,25 in women of II group and 265 ± 0,19 in the control group (p <0,05).

Conclusions. It was demonstrated, that hypertriglyceridemia at pregnancy is a predicator relative to PE development and together with progressive growth of atherogenic indices can be considered as prognostic factor for cardiometabolic pathology, especially in women with undergone severe forms of this pathology. It was established, that the increase of LDH level since the second trimester can also testify to the development of PE and remote cardiac pathology in this category of women.


Download data is not yet available.

Author Biographies

Аnastasiia Aksonova, National O.O. Bogomolets Medical UniversityPerinatal center

Department of obstetrics and gynaecology – 1

Iryna Ventskovskaya, National O.O. Bogomolets Medical UniversityPerinatal center

Department of obstetrics and gynaecology –1

Tatyana Yuzvenko, Ukrainian Scientific-Practical Centre of Endocrine Surgery Transplantation of Endocrine Organs and Tissues Ministry of Health of Ukraine

Department of prevention and treatment of diabetes mellitus


Cunningham, F. G., Leveno, K. J., Bloom, S. L., Hauth, J. C., Rouse, D. J., Catherine, Y. S. (2010). Hypertensive disorders in pregnancy. Williams Obstetrics. New York: Mc Graw Hill Companies, 23, 706–56.

Preeclampsia and maternal mortality: global burden (2013). Available at:

Hypertension in pregnancy (2013). Obstetrics & Gynecology, 122 (5), 1122–1131. doi: 10.1097/01.aog.0000437382.03963.88

Chen, C. W., Jaffe, I. Z., Karumanchi, S. A. (2014). Pre-eclampsia and cardiovascular disease. Cardiovascular Research, 101 (4), 579–586. doi: 10.1093/cvr/cvu018

Mosca, L., Benjamin, E. J., Berra, K., Bezanson, J. L., Dolor, R. J., Lloyd-Jones, D. M. et. al. (2011). Effectiveness-Based Guidelines for the Prevention of Cardiovascular Disease in Women–2011 Update: A Guideline From the American Heart Association. Circulation, 123 (11), 1243–1262. doi: 10.1161/cir.0b013e31820faaf8

Mutsalhanova, Y. S. (2015). Prognostic markers of pre-eclampsia. Modern problems of science and education, 5, 326.

Bafna, A., Maheshwari, R. S., Ved, R. K., Sarkar, P. D., Batham, A. R. (2012). Study of atherogenic indices in nephrotic syndrome. International Journal of Biological and Medical Research, 3 (3), 2257–2260.

Dobiasova, M., Frohlich, J., Sedova, M., Cheung, M. C., Brown, B. G. (2011). Cholesterol esterification and atherogenic index of plasma correlate with lipoprotein size and findings on coronary angiography. The Journal of Lipid Research, 52 (3), 566–571. doi: 10.1194/jlr.p011668

Ikewuchi, J. C., Chigozie, J. (2010). Changes in the Weight, Plasma Lipid Profile and Atherogenic Indices of Salt-Loaded Rats by Aqueous Extract of Acalypha wilkesiana Muell Arg: Potential for Cardiovascular Risk Reduction. The Pacific Journal of Science and Technology, 11 (2), 516–523.

Aryal, M., Poudel, A., Satyal, B., Gyawali, P., Pokheral, B. R., Raut, B. K. et. al. (2012). Evaluation of non-HDL-c and total cholesterol: HDL-c Ratio as Cumulative Marker of Cardiovascular Risk in Diabetes Mellitus. Kathmandu University Medical Journal, 8 (4). doi: 10.3126/kumj.v8i4.6239

Rebrova, O. Y. (2006). Statistical analysis of medical data. The use of the application package STATISTICA. Moscow: Media Sphere, 305.

Nwagha, U. I., Ikekpeazu, E. J., Ejezie, F. E., Neboh, E. E., Maduka, I. C. (2010). Atherogenic index of plasma as useful predictor of cardiovascular risk among postmenopausal women in Enugu, Nigeria. African Health Sciences, 10 (3), 248–252.

Emokpae, M. A., Arogundade, A., Adumanya, S. C. (2013). Use of atherogenic index of plasma in evaluating the potential cardioprotective effects of red wine consumption: Studies in Nigerian young adult volunteers. Biokemistri, 25 (3), 118–123.

Third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III) Final Report (2002). Circulation, 106 (25), 3143–3421. Available at:

Cholesterol ratio: Is it important? Mayo Clinic. Available at:

Kashinakunti, S. V., Sunitha, H., Gurupadappa, K., Manjula, R. (2010). Lipid profile in pre-eclampsia – a case control study. Journal of Clinical and Diagnostic Research, 4 (4), 2748–2751.

Bennal, A., Kammar, K. F. (2012). Role of Triglycerides –In Severity of Pre-Eclampsia. Journal of Physiology and Pharmacology Advances, 2 (11), 360–364.

Munde, S. M., Hazari, N. R., Thorat, A. P., Gaikwad, S. B., Hatolkar, V. S. (2014). Gamma glutamyl transferase and Lactate dehydrogenase as biochemical markers of severity of preeclampsia. International Journal of Medical, Health, Biomedical, Bioengineering and Pharmaceutical Engineering, 8 (1), 50–53.

Bera, S., Gupta, S., Roy, S. S., Kunti, S., Biswas, S., Ghosh, D. (2014). Study of liver enzymes especially lactate degydrogenase to predict foetal outcome in pregnancy induced hypertension. Scholars Journal of Applied Medical Sciences, 2 (5A), 1569–1572.

Kozic, J. R., Benton, S. J., Hutcheon, J. A., Payne, B. A., Magee, L. A., von Dadelszen, P. (2011). Abnormal Liver Function Tests as Predictors of Adverse Maternal Outcomes in Women With Preeclampsia. Journal of Obstetrics and Gynaecology Canada, 33 (10), 995–1004. doi: 10.1016/s1701-2163(16)35048-4

👁 526
⬇ 305
How to Cite
Medicine and Dentistry